7Baggers
Quarterly
Annual
    Unit: USD2023-12-31 2022-12-31 2021-12-31 2020-12-31 2017-12-31 2016-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31 2007-12-31 2005-12-31 2004-12-31 2003-12-31 2002-12-31 
      
    		               
      property, plant and equipment
    		10,160 9,869 10,028 9,365 9,579 10,019 10,750 8,155 7,830 6,961 6,538 6,184 5,886,000,000   
      right-of-use assets
    		1,654 1,815 1,948 1,198            
      goodwill
    		49,404 49,892 48,056 44,364 40,264 40,287 38,079 31,932 29,733 28,163 27,199 30,234 23,475,000,000  134,000,000 
      other intangible assets
    		24,319 21,640 21,407 18,421 13,080 10,879 23,639 12,479       1,161,000,000 
      investments accounted for using the equity method
    		424 677 250 201 2,863           
      other non-current assets
    		3,218 3,095 3,127 2,734 3,364 2,820          
      non-current income tax assets
    		188 242 175 248            
      deferred tax assets
    		6,427 5,381 4,598 4,212 4,290 4,669 3,633 3,051 2,912 2,920 2,912 3,095    
      non-current assets
    		95,794 92,611 89,589 80,743 73,440 71,564 79,307 58,185 56,175 56,584 59,361 73,537    
      inventories
    		9,666 8,960 8,715 8,352 6,816 6,892 6,051 5,020 4,444 3,590 3,729 3,430 3,058,000,000  823,000,000 
      accounts receivable
    		8,433 8,424 7,568 7,491 7,216 7,311 8,042 6,507 6,015 5,303 4,904 5,021 4,501,000,000  1,311,000,000 
      other current assets
    		3,455 3,532 3,571 2,737 2,005 2,211 2,401 2,000 2,104 1,881 2,126 2,434 2,476,000,000  854,000,000 
      current income tax assets
    		391 374 612 1,208            
      cash and cash equivalents
    		8,710 12,736 10,098 13,915 10,315 10,273 4,124 6,465 4,692 4,226 1,711 1,249    
      current assets
    		30,655 34,026 30,564 33,703 26,352 26,687 20,791 20,043 17,532 15,403 12,553 13,121    
      assets held for sale or exchange
    		15 85 89 83 34 6,421 67 7,036 6,342       
      total assets
    		126,464 126,722 120,242 114,529 99,826 104,672 100,165 85,264 80,049 71,987 71,914 86,658 76,755,000,000 9,749,000,000 9,459,000,000 
      f-2
    		               
      equity attributable to equity holders of sanofi
    		    58,089           
      equity attributable to non-controlling interests
    		    169           
      total equity
    		    58,258    48,446 45,071 44,719     
      long-term debt
    		    14,326    5,961 4,173 3,734  8,638,000,000  65,000,000 
      non-current liabilities related to business combinations and to non-controlling interests
    		    1,026           
      non-current provisions and other non-current liabilities
    		    9,154           
      deferred tax liabilities
    		    1,605    4,933 5,668 6,935     
      non-current liabilities
    		    26,111    19,205 17,571 17,526     
      accounts payable
    		    4,633    2,654 2,791 2,749  2,765,000,000  596,000,000 
      current liabilities related to business combinations and to non-controlling interests
    		    343           
      current provisions and other current liabilities
    		    9,206           
      short-term debt and current portion of long-term debt
    		    1,275    2,866 1,833 2,207     
      current liabilities
    		    15,457    10,965 9,345 9,669     
      liabilities related to assets held for sale or exchange
    		        1,433       
      total equity and liabilities
    		    99,826           
      investments in associates and joint ventures
    		     2,890 807 924        
      consolidated balance sheets – liabilities and equity
    		               
      assets
    		               
      non-current financial assets
    		      2,399 1,644        
      current financial assets
    		      173 51        
      in accordance with ifrs 3 (business combinations), sanofi-aventis adjusted the values of certain identifiable assets and liabilities of merial during the purchase price allocation period (see note d.1.).
    		               
      intangible assets
    		        13,747 15,260 19,182 30,229    
      investments in associates
    		        955 2,459 2,493 2,477    
      financial assets — non-current
    		        998 821      
      financial assets — current
    		        277 403      
      liabilities & equity
    		               
      equity attributable to equity holders of the company
    		        48,188 44,866 44,542     
      minority interests
    		        258 205 177  359,000,000  17,000,000 
      provisions and other non-current liabilities
    		        8,311 7,730 6,857     
      other current liabilities
    		        5,445 4,721 4,713  4,852,000,000  1,599,000,000 
      total liabilities & equity
    		        80,049 71,987 71,914     
      assets held for sale
    		           676    
      liabilities related to assets held for sale
    		               
      financial assets – non-current
    		          1,037 1,318    
      financial assets – current
    		          83 311    
      as allowed under ifrs 3, sanofi-aventis has revised certain preliminary estimates of the aventis purchase price allocation within the permitted 12-month period.
    		               
      patents, licenses and other intangibles
    		            29,600,000,000   
      long-term investments
    		               
      equity investees
    		            2,404,000,000   
      other investments and advances
    		            11,000,000   
      other long-term investments
    		            929,000,000  73,000,000 
      total fixed assets
    		            62,305,000,000 2,712,000,000 2,899,000,000 
      deferred income taxes
    		            1,925,000,000 472,000,000 484,000,000 
      short-term investments and deposits
    		            958,000,000  2,944,000,000 
      cash
    		            1,532,000,000  144,000,000 
      in millions of euros
    		               
      liabilities and shareholders’ equity
    		               
      shareholders’ equity
    		               
      share capital
    		            2,823,000,000  1,465,000,000 
      additional paid in capital and reserves
    		            39,377,000,000  2,971,000,000 
      net income for the period
    		              1,759,000,000 
      cumulative translation adjustment
    		               
      total shareholders’ equity
    		            35,574,000,000  6,035,000,000 
      other equity instruments
    		            16,000,000   
      provisions and other long-term liabilities
    		            5,768,000,000  786,000,000 
      short-term debt
    		            7,388,000,000  351,000,000 
      total liabilities and shareholders’ equity
    		            76,755,000,000  9,459,000,000 
      inventories, accounts receivable & other current assets
    		             3,187,000,000  
      short-term investments and deposits, cash
    		             3,378,000,000  
      gross
    		              1,989,000,000 
      accumulated depreciation
    		               
      net
    		              1,395,000,000 
      investments in/advances to equity investees
    		              109,000,000 
      investments in/advances to non-consolidated companies
    		              27,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.